UOC
ANTH

UBS O'Connor’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

UBS O'Connor’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-11,130
Closed -$398K – 914
2015
Q1 		$398K Buy
+11,130
New +$398K 0.01% 542
2013
Q4 		– Sell
-9,063
Closed -$291K – 477
2013
Q3 		$291K Sell
9,063
-312
-3% -$10K 0.01% 333
2013
Q2 		$278K Buy
+9,375
New +$278K 0.01% 428